Your browser doesn't support javascript.
loading
The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer.
van Dijk, Nick; Gil-Jimenez, Alberto; Silina, Karina; van Montfoort, Maurits L; Einerhand, Sarah; Jonkman, Lars; Voskuilen, Charlotte S; Peters, Dennis; Sanders, Joyce; Lubeck, Yoni; Broeks, Annegien; Hooijberg, Erik; Vis, Daniel J; van den Broek, Maries; Wessels, Lodewyk F A; van Rhijn, Bas W G; van der Heijden, Michiel S.
Afiliação
  • van Dijk N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Gil-Jimenez A; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Silina K; Oncode Institute, Utrecht, Netherlands.
  • van Montfoort ML; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Einerhand S; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Jonkman L; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Voskuilen CS; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, Netherlands.
  • Peters D; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Sanders J; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Lubeck Y; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Broeks A; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Hooijberg E; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Vis DJ; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • van den Broek M; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Wessels LFA; Oncode Institute, Utrecht, Netherlands.
  • van Rhijn BWG; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • van der Heijden MS; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Front Immunol ; 12: 793964, 2021.
Article em En | MEDLINE | ID: mdl-34987518
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Auxiliares-Indutores / Linfócitos T CD8-Positivos / Urotélio / Ipilimumab / Nivolumabe / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Auxiliares-Indutores / Linfócitos T CD8-Positivos / Urotélio / Ipilimumab / Nivolumabe / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda